臺大學術典藏 |
2022-06-27T07:06:20Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C. |
臺大學術典藏 |
2022-06-10T06:11:15Z |
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
|
Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; Chen K.-Y.; ZHONG-ZHE LIN; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C. |
臺大學術典藏 |
2022-05-09T06:25:40Z |
Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients
|
Hsu H.-Y.; Chern Y.-J.; Hsieh C.-T.; Yeh T.-L.; Tsai M.-C.; Wang C.-C.; Hsiao B.-Y.; Jhuang J.-R.; Chiang C.-J.; WEN-CHUNG LEE; Chien K.-L. |
臺大學術典藏 |
2022-05-05T08:48:48Z |
Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients
|
Hsu H.-Y.; Chern Y.-J.; Hsieh C.-T.; Yeh T.-L.; Tsai M.-C.; CHIA-CHUN WANG; Hsiao B.-Y.; Jhuang J.-R.; Chiang C.-J.; Lee W.-C.; Chien K.-L. |
臺大學術典藏 |
2022-04-28T12:31:17Z |
Combined healthy lifestyle factors are more beneficial in reducing cardiovascular disease in younger adults: a meta-analysis of prospective cohort studies
|
Tsai M.-C.; Lee C.-C.; Liu S.-C.; Tseng P.-J.; KUO-LIONG CHIEN |
臺大學術典藏 |
2022-04-28T12:31:16Z |
Association between metabolically healthy obesity/overweight and cardiovascular disease risk: A representative cohort study in Taiwan
|
Yeh T.-L.; Hsu H.-Y.; Tsai M.-C.; Hsu L.-Y.; Hwang L.-C.; KUO-LIONG CHIEN |
臺大學術典藏 |
2022-04-28T12:31:14Z |
Association between type 2 diabetes and osteoporosis risk: A representative cohort study in Taiwan
|
Lin H.-H.; Hsu H.-Y.; Tsai M.-C.; Hsu L.-Y.; KUO-LIONG CHIEN; Yeh T.-L. |
臺大學術典藏 |
2022-04-28T12:31:11Z |
Metabolically healthy overweight/obesity and cancer risk: A representative cohort study in Taiwan
|
Lin C.-J.; Chang Y.-C.; Hsu H.-Y.; Tsai M.-C.; Hsu L.-Y.; Hwang L.-C.; KUO-LIONG CHIEN; Yeh T.-L. |
臺大學術典藏 |
2022-04-28T12:31:11Z |
Obesity phenotypes and their relationships with atrial fibrillation
|
Tsai S.-Y.; Chen H.-H.; Hsu H.-Y.; Tsai M.-C.; Hsu L.-Y.; Hwang L.-C.; KUO-LIONG CHIEN; Lin C.-J.; Yeh T.-L. |
臺大學術典藏 |
2022-04-28T12:31:10Z |
Association of baseline as well as change in lipid levels with the risk of cardiovascular diseases and all-cause deaths
|
Hsu H.-Y.; Tsai M.-C.; Yeh T.-L.; Hsu L.-Y.; Hwang L.-C.; KUO-LIONG CHIEN |
臺大學術典藏 |
2022-04-28T12:31:09Z |
Comparison of four healthy lifestyle scores for predicting cardiovascular events in a national cohort study
|
Tsai M.-C.; Yeh T.-L.; Hsu H.-Y.; Hsu L.-Y.; Lee C.-C.; Tseng P.-J.; KUO-LIONG CHIEN |
臺大學術典藏 |
2022-04-28T12:31:09Z |
Lipid biomarkers and Cancer risk - a population-based prospective cohort study in Taiwan
|
Chang Y.-C.; Lin C.-J.; Yeh T.-L.; Tsai M.-C.; Hsu L.-Y.; KUO-LIONG CHIEN; Hsu H.-Y. |
臺大學術典藏 |
2022-04-28T12:31:08Z |
Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients
|
Hsu H.-Y.; Chern Y.-J.; Hsieh C.-T.; Yeh T.-L.; Tsai M.-C.; Wang C.-C.; Hsiao B.-Y.; Jhuang J.-R.; Chiang C.-J.; Lee W.-C.; KUO-LIONG CHIEN |
臺大學術典藏 |
2022-04-26T06:18:08Z |
Automatic Kidney Volume Estimation System Using Transfer Learning Techniques
|
Hsiao C.-H;Tsai M.-C;Lin F.Y.-S;Lin P.-C;Yang F.-J;Yang S.-Y;Wang S.-Y;Liu P.-R;Huang Y.; Hsiao C.-H; Tsai M.-C; Lin F.Y.-S; Lin P.-C; Yang F.-J; Yang S.-Y; Wang S.-Y; Liu P.-R; Huang Y.; YEONG-SUNG LIN |
臺大學術典藏 |
2022-04-21T06:51:52Z |
Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-Deprenyl in vivo
|
Liou H.-H.; Chen R.-C.; Chen, Tony Hsiu Hsi; Tsai Y.-F.; Tsai M.-C. |
臺大學術典藏 |
2022-04-21T06:51:26Z |
Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: Geographic variations among 502 villages in southern Taiwan
|
Tsai M.-C.; Kee K.-M.; Chen Y.-D.; Lin L.-C.; Tsai L.-S.; Chen, Tony Hsiu Hsi; Lu S.-N. |
臺大學術典藏 |
2022-04-21T06:50:48Z |
Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
|
Chang K.-C.; Wu Y.-Y.; Hung C.-H.; Lu S.-N.; Lee C.-M.; Chiu K.-W.; Tsai M.-C.; Tseng P.-L.; Huang C.-M.; Cho C.-L.; Chen, Tony Hsiu Hsi; Hu T.-H. |
臺大學術典藏 |
2022-04-21T06:50:39Z |
A polymorphism in interferon L3 Is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis c virus infection
|
Chang K.-C.; Tseng P.-L.; Wu Y.-Y.; Hung H.-C.; Huang C.-M.; Lu S.-N.; Wang J.-H.; Lee C.-M.; Chen C.-H.; Tsai M.-C.; Yen Y.-H.; Lin M.-T.; Wu C.-K.; Huang C.-C.; Chen, Tony Hsiu Hsi; Hu T.-H. |
臺大學術典藏 |
2022-04-20T08:12:02Z |
Increased standardised incidence ratio of cardiovascular diseases among colorectal cancer patients
|
Hsu H.-Y.; Chern Y.-J.; Hsieh C.-T.; Yeh T.-L.; Tsai M.-C.; Wang C.-C.; Hsiao B.-Y.; Jhuang J.-R.; CHUN-JU CHIANG; Lee W.-C.; Chien K.-L. |
臺大學術典藏 |
2022-04-15T03:14:32Z |
Est1p as a cell cycle-regulated activator of telomere-bound telomerase
|
SHU-CHUN TENG; Tsai H.-J.; Tsai M.-C.; Lee W.-M.; Chen I.-C.; Lin C.-C. |
臺大學術典藏 |
2022-03-30T05:44:42Z |
Designed a new workstation and flowmeter for local ventilation
|
Tsai M.-C.; JIA-KUN CHEN; Tseng T.-I. |
臺大學術典藏 |
2022-03-17T06:36:25Z |
Gastrointestinal: Afferent loop syndrome
|
Herbella F.A.M.; Lee T.-C.; Matone J.; Del Grande J.C.; Liu K.-L.; Tsai M.-C.; MING-TAI LIN; Wang H.-P. |
臺大學術典藏 |
2022-02-23T08:10:48Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Wu C.C.; Lin L.Y.; Lin L.C.; HUI-CHUN HUANG; Yang Y.F.; Liu Y.B.; Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; Tseng W.Y.I.; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K. |
臺大學術典藏 |
2022-02-23T08:10:47Z |
Two-dimensional propagation of magnetocardiac T wave signals for characterizing myocardial ischemia
|
Wu C.C.; HUI-CHUN HUANG; Liu Y.B.; Lin L.C.; Lin L.Y.; Chen M.F.; Tsai M.C.; Gao Y.L.; Yang S.Y.; Horng H.E.; Yang H.C.; Tseng W.K.; Lee T.L.; Hsuan C.F.; Pan Y.F.; Lee Y.H. |
臺大學術典藏 |
2022-02-23T02:12:22Z |
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment
|
Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F. |
臺大學術典藏 |
2022-02-23T02:12:21Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
臺大學術典藏 |
2022-02-23T02:12:21Z |
Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
|
Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H. |
臺大學術典藏 |
2022-02-23T02:12:17Z |
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection
|
Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H. |
臺大學術典藏 |
2022-02-22T05:34:11Z |
Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment
|
Lin M.-T.; Chang K.-C.; Yen Y.-H.; Tsai M.-C.; CHIEN-HUNG CHEN; Wang J.-H.; Hsiao C.-C.; Chiu Y.-H.; Hu T.-H. |
臺大學術典藏 |
2022-02-22T05:34:11Z |
Use of glecaprevir/pibrentasvir in patients with chronic hepatitis c virus infection and severe renal impairment
|
Yap D.Y.H.; Liu K.S.H.; Hsu Y.-C.; Wong G.L.H.; Tsai M.-C.; CHIEN-HUNG CHEN; Hsu C.-S.; Hui Y.T.; Li M.K.K.; Liu C.-H.; Kan Y.-M.; Yu M.-L.; Yuen M.-F. |
臺大學術典藏 |
2022-02-22T05:34:10Z |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; CHIEN-HUNG CHEN; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; Liu C.-J.; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
臺大學術典藏 |
2022-02-22T05:34:07Z |
Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection
|
Tsai M.-C.; Wang C.-C.; Lee W.-C.; Lin C.-C.; Chang K.-C.; CHIEN-HUNG CHEN; Hung C.-H.; Lin M.-T.; Hsiao C.-C.; Chen C.-L.; Chien R.-N.; Hu T.-H. |
臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:31:11Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:31:00Z |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang C.-F.; Tseng K.-C.; Cheng P.-N.; Hung C.-H.; Lo C.-C.; Peng C.-Y.; Bair M.-J.; Yeh M.-L.; Chen C.-H.; Lee P.-L.; Lin C.-Y.; Kuo H.-T.; Chen C.-T.; Yang C.-C.; Huang J.-F.; Tai C.-M.; Hu J.-T.; Lin C.-L.; Su W.-W.; Tsai W.-L.; Huang Y.-H.; Cheng C.-Y.; Lin C.-L.; Wang C.-C.; Yang S.-S.; Mo L.-R.; Chen G.-Y.; Chang C.-C.; Wang S.-J.; Huang C.-S.; Hsieh T.-Y.; Lin C.-W.; Lee T.-H.; Chong L.-W.; Huang C.-W.; Chang S.-N.; Tsai M.-C.; Hsu S.-J.; Kao J.-H.; CHUN-JEN LIU; Liu C.-H.; Lin H.-C.; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; Chuang W.-L.; Chen C.-Y.; Yu M.-L. |
臺大學術典藏 |
2022-01-24T09:30:59Z |
Sofosbuvir/Velpatasvir for Hepatitis?C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng P.-N.; Mo L.-R.; Chen C.-T.; Chen C.-Y.; Huang C.-F.; Kuo H.-T.; Lo C.-C.; Tseng K.-C.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Chou K.-H.; Kao C.-N.; Tsai P.-C.; Liu C.-H.; Lee M.-H.; Cheng C.-Y.; Tsai M.-C.; CHUN-JEN LIU; Dai C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Yu M.-L.; TACR investigators |
臺大學術典藏 |
2022-01-24T09:30:58Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
臺大學術典藏 |
2022-01-24T09:30:53Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
臺大學術典藏 |
2022-01-19T09:30:10Z |
Characterization and relative abundance of maxi-chloride channels in Epstein-Barr virus (EBV) producer: B95-8 cells
|
TE-HUEI YEH; Tsai M.C.; Lee S.Y.; Hsu M.M. |
臺大學術典藏 |
2022-01-19T09:30:09Z |
Characterization of Ca2+- and voltage-dependent nonselective cation channels in human HepG2 cells
|
Chen W.-H.; TE-HUEI YEH; Tsai M.-C.; Chen D.-S.; Wang T.-H. |
臺大學術典藏 |
2022-01-19T09:30:09Z |
Stretch-activated nonselective cation, Cl- and K+ channels in apical membrane of epithelial cells of Reissner's membrane
|
TE-HUEI YEH; Tsai M.-C.; Lee S.-Y.; Hsu M.-M.; Tran Ba Huy P. |
臺大學術典藏 |
2022-01-19T09:30:08Z |
A cationic nonselective stretch-activated channel in the Reissner's membrane of the guinea pig cochlea
|
TE-HUEI YEH; Herman P.; Tsai M.-C.; Tran Ba Huy P.; Van Den Abbeele T. |
臺大學術典藏 |
2022-01-19T09:29:53Z |
Pathology quiz case 1
|
Tsai M.-C.; TE-HUEI YEH; Chang W.-H. |
國立成功大學 |
2022 |
Acceleration-based FIR filters for trajectory interpolation with different kinematic constraints and target velocities for NC systems
|
Huang, R.-Y.;Cheng, Cheng C.-W.;Tsai, M.-C.;Lee, A.-C. |
國立成功大學 |
2022 |
Tiny Piezoelectric Multi-Layered Actuators with Application in a Compact Camera Module—Design, Fabrication, Assembling and Testing Issues
|
Lee, C.-P.;Tsai, M.-C.;Fuh, Y.-K. |
國立成功大學 |
2022 |
Development of a Dual-Input Magnetic Gear Train for the Transmission System of Small-Scale Wind Turbines
|
Wu, Y.-C.;Ou, F.-M.;Tsai, M.-C.;Fajri, S.N. |
國立成功大學 |
2022 |
Additive manufacturing of NdFeB magnets by synchronized three-beam laser powder bed fusion
|
Yu, K.-S.;Cheng, Cheng C.-W.;Lee, A.-C.;Jhang, Jian W.-Y.;Chang, W.-C.;Chang, T.-W.;Tsai, M.-C. |
國立成功大學 |
2022 |
Novel diagonal scanning strategy for the laser powder bed fusion process
|
Huang, R.-Y.;Lin, M.-H.;Lai, R.-S.;Cheng, Cheng C.-W.;Tsai, M.-C.;Lee, A.-C. |